Hexima Ltd. is a clinical stage, anti-infectives focused biotechnology company. It engages in the business of researching and developing plant-derived proteins for applications as human therapeutics. The company was founded by Adrienne E. Clarke, Marilyn Ann Anderson, Robyn L. Heath, and Angela Atkinson in 1998 and is headquartered in Preston, Australia.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company